• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us

Indian pharma

Opening Indian pharma’s Bottle of Lies

July 12, 2019 By Vertika Kanaujia Leave a Comment

“They often make their worst drugs — with the lowest-quality ingredients and the most manufacturing shortcuts — for the least regulated markets, including India,” writes investigative journalist Katherine Eban in her book Bottle of Lies: The Inside Story of the Generic Boom (also subtitled as Ranbaxy and the Dark Side of Indian Pharma), an exposé […]

Filed Under: Featured, Featured Story, International, Medicine and Research, National, Social issues Tagged With: access to medicines, generic medicines, Indian pharma, industry

Anti-rabies vaccine shortages continue

May 1, 2019 By Kerean Watts Leave a Comment

An Indian Army vet administers the anti-rabies vaccine to a dog.

Shortages of the anti-rabies vaccine and other essential medicines continue to plague public hospitals across the country, with states turning to one another for assistance. So far, the onus for supply has been on Tamil Nadu. Andhra Pradesh, Delhi and Karnataka have also requested for supplies of essential medicines including the anti-rabies vaccine from the […]

Filed Under: Access to Healthcare, Featured Stories, Government policy, Infectious diseases, Medicine and Research, National, News, Social issues Tagged With: access to healthcare, access to medicines, Andhra Pradesh, China, Delhi, Indian pharma, Karnataka, pharma, rabies, Tamil Nadu, vaccines

Pharma fears over Jan Aushadhi

March 19, 2019 By Kerean Watts Leave a Comment

The Centre’s flagship access to medicines scheme may be a boon for patients. However, it is also stoking fears among Indian pharma. Forecasts estimate that drugmakers could see twenty percent of their sales disrupted by the Pradhan Mantri Bhartiya Jan Aushadhi Pari Yojana Kendra (PMBJPK), a health ministry campaign to make medicines more affordable for […]

Filed Under: Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News Tagged With: access to healthcare, access to medicines, generic medicines, Indian pharma

Jan Aushadhi Diwas: What the Prime Minister said

March 8, 2019 By Kerean Watts Leave a Comment

Prime Minister Narendra Modi

Jan Aushadhi Diwas celebrations heralded the Centre’s scheme to expand access to medicines – and included a high-profile speech from Prime Minister Modi, in which he extolled the benefits of the initiative. Beneficiaries of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) include both the poor and middle-class, the Prime Minister claimed during a video conference […]

Filed Under: Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News, Social issues Tagged With: access to healthcare, access to medicines, generic medicines, Generics, Indian pharma, Narendra Modi, Pharmacy

Generic medicines: Centre pushes for cheaper drugs

March 5, 2019 By Kerean Watts Leave a Comment

In a bid to make generic medicines more eye-catching, the Central government is planning to introduce an innovative marketing strategy to increase their brand awareness among consumers. New Union Health Ministry plans would colour-code generic medicines to distinguish them from their more costly brand-name counterparts. This is in a bid to encourage consumers to make […]

Filed Under: Access to Healthcare, Featured, Government policy, Medicine and Research, National, News, Social issues Tagged With: access to healthcare, access to medicines, Ayushman Bharat, generic medicines, Generics, government policy, Indian pharma, pharma, Pharmacy

Saridon gets ban reprieve from Supreme Court

February 22, 2019 By Kerean Watts Leave a Comment

Market stockists, 64323511 - medical pharmacy or drugstore interior design. chemist or apothecary, dispensary and clinical, ambulatory or community shop for pills or tablets, lozenge in flasks. medicine and healthcare theme 64323511 - medical pharmacy or drugstore interior design. chemist or apothecary, dispensary and clinical, ambulatory or community shop for pills or tablets, lozenge in flasks. medicine and healthcare theme

A ban on painkiller Saridon has been lifted by the Supreme Court. The headache relief medicine  was one of the 343 fixed dose combination (FDC) drugs banned in a notification by the Centre last year. FDCs are pharmaceutical products which contain two or more active pharmaceutical ingredients (APIs). Safety concerns drove the Centre’s decision to […]

Filed Under: Access to Healthcare, Featured, Government policy, Medicine and Research, National, News Tagged With: Indian pharma, pharma, Supreme Court

Centre plans ban on combination medications: SC repeals some

September 13, 2018 By Kerean Watts Leave a Comment

The Supreme Court has reversed plans by the Centre to ban three of the 328 combination medications it announced plans to ban last week over safety concerns.  Saridon, Piriton and Dart are the three products given a reprieve by the apex court. The ban will still apply to 325 of 343 fixed dose combination (FDC) medications whose […]

Filed Under: Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News, Social issues Tagged With: access to medicines, drug quality, drug resistance, government policy, Indian pharma, law, Substandard drugs, Supreme Court

Centre lifts ban on sales of life-saving drug Oxytocin

August 23, 2018 By Kerean Watts Leave a Comment

Copyright: prashantzi / 123RF Stock Photo

The Centre has revoked its decision to ban retail sale of Oxytocin, a life saving drug for pregnant women in India after petitioners moved court. But tight restrictions remain in place. Oxytocin is a hormone drug used in the treatment of postpartum haemorrhage (PPH), the predominant cause of maternal mortality in India. Its misuse in […]

Filed Under: Access to Healthcare, Featured Stories, Government policy, Medicine and Research, National, News, Social issues Tagged With: access to medicines, Delhi High Court, drug prices, government policy, Indian pharma, maternal healthcare, maternal mortality, MoHFW, Oxytocin, women's health, women's rights

Indian biotech, vaccines and device industries get World Bank cash

May 9, 2018 By Kerean Watts Leave a Comment

Indian innovation will benefit from a US$125 million loan from the World Bank. This follows an agreement signed by the Indian government and the World Bank’s investment arm, the International Bank for Reconstruction and Development (IBRD). The loan will target India’s biopharmaceutical and medical devices sectors through the ‘Innovate in India for Inclusiveness’ project, also […]

Filed Under: Access to Healthcare, Featured, Government policy, International, Medicine and Research, News, Science and Technology, Social issues Tagged With: access to healthcare, access to medicines, Features, health, Indian pharma, industry, Medical devices, vaccines

Indian pharma saves high-quality APIs for the first world. Indians get cheap Chinese imports.

February 25, 2018 By Nicholas Parry Leave a Comment

China

India’s health sector and medical industry may see negative effects in the future stemming from an over reliance on imports of medicine and raw materials from China, claims the Indian Pharmaceutical Congress Association (IPCA), the apex organisation for Indian pharmacists. However, these Chinese raw materials are used in medicines destined for domestic consumption and for […]

Filed Under: Access to Healthcare, Featured, Government policy, International, Medicine and Research, News Tagged With: access to medicines, China, drug quality, Features, health, Indian pharma, world

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.